Publications by authors named "Daniel Judge"

Claim this Profile
A
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.
Julian D Gillmore, Daniel P Judge, Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia

Future Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the impact of recruitment message content on open rate and consent rate for population-based genomic screening.
Carolina Liskey, Daniel Judge, Kelly J Hunt, Samantha Norman, Julia Wakser

J Clin Transl Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes Among Patients in the United States Receiving Tafamidis for Transthyretin Amyloid Cardiomyopathy.
Daniel P Judge, Margarita Udall, Andrew M Rosen, Neil Lamarre, Elizabeth Nagelhout

Cardiol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Nexus of Genotype and Phenotype in Nexilin-Related Genetic Cardiomyopathy.
Nosheen Reza, Daniel P Judge

JACC Heart Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension.
Kevin M Alexander, Margot K Davis, Olakunle Akinboboye, John Berk, Kunal Bhatt, Daniel P Judge

JAMA Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of PDR3 alters metabolome in response to MCHM, a synthetic hydrotrope.
Taizina Momtareen, Michael C Ayers, Dionysios Patriarcheas, Liam McCarthy, Daniel Judge

Curr Genet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management.
Steven A Muller, Giorgia Bertoli, Jianan Wang, Alessio Gasperetti, Moniek G P J Cox, Daniel P Judge

J Cardiovasc Electrophysiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort.
Natalie Telis, Hang Dai, Ashley Waring, David Kann, Dana Wyman, Daniel P Judge

JACC Basic Transl Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLK15 alters connective tissues in hypermobile Ehlers-Danlos syndrome.
Cortney Gensemer, Taylor Petrucci, Tyler Beck, Victoria Daylor, Molly Griggs, Daniel P Judge

iScience· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CM.
Ahmad Masri, Daniel P Judge, Frederick L Ruberg, Julian D Gillmore, Justin L Grodin

J Am Coll Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up.
Ahmad Masri, Mandar Aras, Martha Grogan, Daniel Jacoby, Mathew S Maurer, Daniel P Judge

J Card Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Precision Medicine for Dilated Cardiomyopathy: Insights From the DCM Consortium.
Elizabeth Jordan, Hanyu Ni, Patricia Parker, Daniel D Kinnamon, Anjali Owens, Daniel P Judge

Circ Genom Precis Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers.
Natalie Telis, Lisa McEwen, Alexandre Bolze, Joshua H Lipschutz, Leon W Sweer, Daniel P Judge

HGG Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribution of truncating variants to human cardiomyopathy.
Brendan J Floyd, Joyce N Njoroge, Vikki A Krysov, Bruna Gomes, Ryan Murtha, Daniel Judge

medRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Women with Peripartum or Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study.
Evan P Kransdorf, Rashmi Jain, Jonathan O Mead, Garrie Haas, Mark Hofmeyer, Daniel P Judge

medRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine Study.
Hanyu Ni, Jinwen Cao, Daniel D Kinnamon, Elizabeth Jordan, Garrie J Haas, Daniel P Judge

Circ Heart Fail· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy.
Mathew S Maurer, Daniel P Judge, Julian D Gillmore, Pablo Garcia-Pavia, Ahmad Masri

J Am Coll Cardiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants.

JAMA Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study.
Javier Jimenez, Hanyu Ni, Stuart D Katz, Garrie J Haas, Jinwen Cao, Daniel P Judge

Circ Genom Precis Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial.
Daniel P Judge, Julian D Gillmore, Kevin M Alexander, Amrut V Ambardekar, Francesco Cappelli

Circulation· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy.
Daniel P Judge, Kevin M Alexander, Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia

J Am Coll Cardiol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using technology to increase reach and optimize consent experience for a large-scale research program.
Emma Coen, Daniel P Judge, Samantha Norman, John T Clark, Andrew Cates

J Clin Transl Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Acoramidis on Myocardial Structure and Function in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Cardiac Magnetic Resonance (CMR) Substudy.
Yousuf Razvi, Daniel P Judge, Ana Martinez-Naharro, Adam Ioannou, Lucia Venneri

Circ Heart Fail· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes.
Kelly M Schiabor Barrett, Natalie Telis, Lisa M McEwen, Evanette K Burrows, Basil Khuder, Daniel P Judge

Commun Med (Lond)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Precision Medicine for Dilated Cardiomyopathy: Insights from The DCM Consortium.
Elizabeth Jordan, Hanyu Ni, Patricia Parker, Daniel D Kinnamon, Anjali Owens, Daniel P Judge

medRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis